Over the long term, LMNT plans to strengthen its presence in India’s mid-market hotel segment, aiming to scale up to 30,000-40,000 keys
The company posted a weak quarter but expects to do better, going forward
Margin expansion expected in FY26, backed by lower funding cost
The company has multiple levers to power growth
Investments in capacity, digitisation, and new product development—particularly in clean and hybrid energy systems—suggest that growth momentum will continue
The bank’s valuation remains the main attraction
The company is not profitable at the moment and may continue to make losses in the near term
India’s limited share in the CRDMO market presents strong headroom for growth
While the management remains confident about the business, declining margin remains a concern
The stock correction offers value, as the capex cycle picks up and long-term transmission outlook stays strong
Future growth to be fuelled by several catalysts, and it could emerge as a stronger player in the healthcare space
Titan continues to gain market share in the key jewellery business. The ramping up of the international jewellery segment and the non-jewellery business remains an additional growth trigger
Easing palm oil prices, strong innovations will drive sequential volume growth
Underlying volume growth continues to remain strong
Despite subdued performance in the IoT segment due to restructuring, the company saw continued traction across fintech, logistics, public sector, and automotive verticals.
Q1 performance in line with expectations; the demand outlook is strong, and the stock valuation is attractive
Even as it faces a trade war with the US, China’s share in global exports has increased over the years. For India, replicating this story will not be easy
While a 25 percent tariff significantly undermines the viability of trade with US, a 50 percent tariff will effectively kill it
Trump’s punitive tariff could cloud India’s ambition of becoming a viable alternative to China unless trade negotiations succeed. However, it could well turn out to be India’s 1991 moment, forcing the country to take long-pending economic reforms to leap into the next level
The company’s strategy of better sourcing terms in the wake of increased volumes, sustained pricing discipline, and continued focus on own brands would enable it to sustain margins.
R&D activities around peptides and contrast media remain the two medium-term growth drivers for the company. US tariffs are a near-term risk.
Cement demand is promising in India, though there’s a shift in the competitive landscape
Market share gain in core segments, and strategic focus on premium variants will drive profitable growth
Revenue growth aided by exports; margin dips on currency and cost pressures
The company is poised to benefit from export opportunities as European nations seek partnerships with Indian defence manufacturers to overcome supply-chain constraints and capacity limitations